The TMVR procedure with SAPIEN M3 involves dock and valve delivery via a percutaneous femoral vein guide sheath.

Edwards Lifesciences has claimed an FDA approval for its Sapien M3 transcatheter mitral valve replacement system—marking the ...

First-of-its-kind Edwards SAPIEN M3 transcatheter mitral valve system secures FDA approval for transseptal mitral ...

Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...

The US Food and Drug Administration has approved the Sapien M3 system for transseptal transcatheter mitral valve replacement (TMVR) for use in patients with symptomatic moderate-to-severe mitral ...

Edwards Lifesciences (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first ...

Our multidisciplinary cardiovascular team collaborates on mitral valve repair, transcatheter technologies, mitral valve replacement, and follow-up treatment so patients can get all their care for ...

Open heart surgery for aortic or mitral valve repair or replacement has traditionally required opening the patient’s chest through their sternum (breast bone). In many cases today, a minimally ...

For all the innovation, engineering, and miniaturization that has helped to refine surgical and transcatheter aortic valve replacement over the last few decades, they still fall short of ideal. That ...

Transcatheter aortic valve replacement (TAVR) is valve replacement without open-heart surgery. It is also called catheter-based or percutaneous (through the skin) aortic valve replacement. While ...

Affluent Medical recently announced agreements to acquire Caranx Medical and Artedrone to form a new medtech company called ...

The aortic valve sits between the heart’s left ventricle and the aorta. It opens and closes with the heartbeat to allow blood to flow to the body without leaking back into the heart. It may need to be ...